HEMAZAL Trademark

Trademark Overview

On Tuesday, June 25, 2002, a trademark application was filed for HEMAZAL with the United States Patent and Trademark Office. The USPTO has given the HEMAZAL trademark a serial number of 78138429. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, October 8, 2006. This trademark is owned by Pharmion Corporation. The HEMAZAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and blood disease and for the treatment and alleviation of symptoms related thereto

General Information

Serial Number78138429
Word MarkHEMAZAL
Filing DateTuesday, June 25, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, October 8, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 15, 2003

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer and blood disease and for the treatment and alleviation of symptoms related thereto

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 3, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePharmion Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NamePharmion Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Wednesday, April 30, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 30, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 20, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, December 13, 2006ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 8, 2006EXTENSION 5 GRANTED
Wednesday, March 8, 2006EXTENSION 5 FILED
Wednesday, March 8, 2006TEAS EXTENSION RECEIVED
Monday, September 12, 2005EXTENSION 4 GRANTED
Monday, September 12, 2005EXTENSION 4 FILED
Monday, September 12, 2005TEAS EXTENSION RECEIVED
Friday, February 25, 2005EXTENSION 3 GRANTED
Thursday, February 10, 2005EXTENSION 3 FILED
Thursday, February 10, 2005TEAS EXTENSION RECEIVED
Friday, September 17, 2004EXTENSION 2 GRANTED
Wednesday, September 8, 2004EXTENSION 2 FILED
Wednesday, September 8, 2004TEAS EXTENSION RECEIVED
Thursday, March 25, 2004EXTENSION 1 GRANTED
Thursday, March 25, 2004EXTENSION 1 FILED
Wednesday, March 31, 2004CASE FILE IN TICRS
Thursday, March 25, 2004TEAS EXTENSION RECEIVED
Tuesday, October 7, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 15, 2003PUBLISHED FOR OPPOSITION
Wednesday, June 25, 2003NOTICE OF PUBLICATION
Monday, May 12, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 17, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 17, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 30, 2002NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2002ASSIGNED TO EXAMINER

Related Keywords

hemazal treatment symptoms related alleviation thereto blood preparations cancer pharmaceutical disease